Terumo had 16 patents in artificial intelligence during Q1 2024.Terumo Corp’s patents for Q1 2024 focus on medical systems utilizing catheters with sensors for imaging luminal organs. The systems incorporate machine learning models to analyze images, predict patient prognosis, determine stent sizes, and provide support information for medical operations or diagnoses. Additionally, the patents include an information processing device for analyzing time-series data of patients and a program for specifying and displaying directions of interest in medical images obtained through catheter imaging. GlobalData’s report on Terumo gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Terumo Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Terumo grant share with artificial intelligence as a theme is 25% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Medical system, method for processing medical image, and medical image processing apparatus (Patent ID: US20240013385A1)

The patent filed by Terumo Corp. describes a medical system that includes a catheter with a sensor for insertion into a luminal organ, a display apparatus, and an image processing apparatus. The image processing apparatus generates an image of the organ, inputs it to a machine learning model to identify objects, determines the size of a stent needed based on the object type and region, and displays information about the stent size. The system is particularly useful for blood vessels, where it can calculate plaque burdens, identify lesions, determine stent diameters, landing zones, and lengths, and select the appropriate stent type based on availability.

Furthermore, the patent also outlines a method for processing medical images of luminal organs, specifically blood vessels with plaque. The method involves generating images using a catheter sensor, inputting them into a machine learning model to identify objects like plaque, determining stent sizes based on object characteristics, and displaying the necessary information. It includes steps for calculating plaque burdens, identifying lesions, determining stent diameters, landing zones, lengths, and selecting the appropriate stent type based on availability. This method streamlines the process of determining stent sizes and types for implantation in luminal organs, particularly blood vessels affected by plaque build-up.

To know more about GlobalData’s detailed insights on Terumo, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.